Owners, management and financials
CVR: 44226189
DKK -483,088
Gross profit
Net result: DKK -3,540,377
Northgaard Holding ApS (5-9,99%), Ditte Boilesen Holding ApS (33,33-49,99%)
1 more
CVR · view owners
Ditte Rahbæk Boilesen, Stephanie Holstein-Rønsbo
Board: Alejandra Maria Cristina Bonifacini Mørk (chair) and 3 members
CVR · view management
Active
Founded 9 August 2023
CVR · view overview
5 employees
Annual report 2025 · average
Owner registered: Northgaard Holding ApS
CVR · 13/01/2025
View the full event history
Loma Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ditte Rahbæk Boilesen and Stephanie Holstein-Rønsbo. The board consists of Alejandra Maria Cristina Bonifacini Mørk (chair), Leif Helth Jensen, Ralf Wagner and Stuart John Myles Collinson. The company is owned by Northgaard Holding ApS, Ditte Boilesen Holding ApS and Holstein-Rønsbo Holding ApS. According to the 2025 annual report, the company had an average of 5 employees. In 2025, the company reported a gross profit of DKK -483,088 and a net result of DKK -3,540,377. Equity in the 2025 report amounted to DKK -8,121,947.
Selskabets formål er at foretage forskning, udvikling og kommercialisering inden for medicinske produkter.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -483 t. | -3.5 mio. | 7.3 mio. | -8.1 mio. | 5 |
Compared to 1.039 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Loma Therapeutics ApS is 44226189.
Loma Therapeutics ApS is owned by Northgaard Holding ApS, Ditte Boilesen Holding ApS and Holstein-Rønsbo Holding ApS.
The management of Loma Therapeutics ApS consists of Ditte Rahbæk Boilesen and Stephanie Holstein-Rønsbo.
The board of Loma Therapeutics ApS consists of Alejandra Maria Cristina Bonifacini Mørk, Leif Helth Jensen and Ralf Wagner, with Alejandra Maria Cristina Bonifacini Mørk as chair.
In 2025, Loma Therapeutics ApS reported a gross profit of DKK -483,088.
Loma Therapeutics ApS had an average of 5 employees in the 2025 financial year according to the annual report.
Claim this page to add your logo and social links. Free to get started.
Loma Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -483,088, and the net result was DKK -3,540,377.
As of May 22, 2026, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Loma Therapeutics ApS.
Loma Therapeutics ApS has published its interim report for the period August 9, 2023 – December 31, 2024.
As of January 13, 2025, Alejandra Maria Cristina Bonifacini Mørk has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Leif Helth Jensen has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Stuart John Myles Collinson has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Ralf Wagner has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Northgaard Holding ApS is registered as an owner of Loma Therapeutics ApS with an ownership share of 5%.
As of February 7, 2024, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Loma Therapeutics ApS.
As of February 7, 2024, Taastrup 2024 P/S has stepped down as auditor of Loma Therapeutics ApS.
As of August 9, 2023, Taastrup 2024 P/S has been appointed auditor of Loma Therapeutics ApS.
As of August 9, 2023, Ditte Rahbæk Boilesen is registered as director of Loma Therapeutics ApS.
As of August 9, 2023, Stephanie Holstein-Rønsbo is registered as director of Loma Therapeutics ApS.
As of August 9, 2023, Ditte Boilesen Holding ApS is registered as an owner of Loma Therapeutics ApS with an ownership share of 33%.
As of August 9, 2023, Holstein-Rønsbo Holding ApS is registered as an owner of Loma Therapeutics ApS with an ownership share of 33%.
Loma Therapeutics ApS was founded on August 9, 2023.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at drive forretning med digital markedsføring og strategi samt enhver i forbindelse hermed stående virksomhed.
Companies in the same industry and area
CVR 36465972
CVR 45436497
CVR 46543912
CVR 44478587
CVR 31427169
